Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1CNS 1Breast 1

Conditions

Melanoma 1Lymphoma, T-Cell, Peripheral 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

pembrolizumab 603Cyclophosphamide 545Magnetic Resonance Spectroscopy 527Radiotherapy 513Specimen Handling 505Nivolumab 411Cisplatin 381Carboplatin 369Biopsy 305Blood Specimen Collection 304Radiosurgery 290Paclitaxel 281Gemcitabine 271Surveys and Questionnaires 269Standard of Care 267fludarabine 263Drug Therapy 263Dexamethasone 263Bevacizumab 252venetoclax 251Oxaliplatin 209Capecitabine 199Rituximab 198Radiation 191Ipilimumab 188Fluorouracil 188durvalumab 185Doxorubicin 178Etoposide 177atezolizumab 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Salvage Therapy × 1 year × Clear all
NCT07470996 2026-03-13

T-START-NR

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Recruiting
58 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT03340129 2026-02-02

ABC-X

Melanoma Institute Australia

Phase 2 Recruiting
218 enrolled
CNSDermatologic

Brain Neoplasms, Melanoma

NCT05933733 2025-06-29

SALT-LRR

Samsung Medical Center

Recruiting
190 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡